© Johanna Stöckl

minoo service

Molecular SARS-CoV-2 test – with maximum support

The minoo SARS-CoV-2 test convinces both with its speed and performance and with its intuitive, self-explanatory user-friendliness.

Healthcare professionals will only need a short familiarisation phase to use minoo. Our flexible service is at your disposal to optimise this training phase, the integration of minoo into your workflow and the ongoing support itself.

​Processes

Hardly any effort

We are keeping the service for the molecular SARS-CoV-2 test with minoo as simple and effective as our product itself.

We present the concept to you on site, explain the procedures for optimized testing and then prepare a detailed quotation. After that, your healthcare professionals are instructed in product handling and they will supervise a test run on site.

Our services at a glance:

Needs analysis with specific proposals and detailed offer
Analysis of your processes and needs on site
Training for healthcare professionals—online or on site
Product training and provision of training material such as training videos and information about the product
Latest developments and practical experience from the everyday use of our customer pool

Benefits

Great Utility

© peopleimages.com | Adobe Stock

In addition to protecting staff health, molecular SARS-CoV-2 testing on-site actively helps reduce the workload of employees.

It eliminates the need to go to external test centres or doctors’ offices, which minimises stress for employees and significantly increases the acceptance of regular testing.

Advantages of the on-site molecular SARS-CoV-2 test

Healthcare professional prepares the sample on site
Molecular test (NAT test) provides high quality results
Short wait: test results in 18 minutes
Robustness with respect to viral mutation as a result of the test system
Consistent test reliability due to production in a certified environment
Significantly less effort for staff

Important Notice:

minoo is CE marked but only available in Germany and India

You have Successfully Subscribed!